Jim LaFrance

Jim LaFrance has joined the board of platelet activiation technology firm LightIntegra Technology. LaFrance is currently chairman of the board at Vermillion, executive chairman of Bioarray Genetics, and he serves on the board of HTG Molecular and Personal Genome Diagnostics. He was interim CEO of Vermillion, CEO of Omnyx within GE Healthcare, CEO and president of LaFrance Consulting, and head of international commercial operations at Ventana, now part of Roche.